Yanal Ghosheh
Overview
Explore the profile of Yanal Ghosheh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pattarabanjird T, Nguyen A, McSkimming C, Dinh H, Marshall M, Ghosheh Y, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(12):1328.
PMID: 39196158
No abstract available.
2.
Pattarabanjird T, Nguyen A, McSkimming C, Dinh H, Marshall M, Ghosheh Y, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(11):1003-1014.
PMID: 39196097
IgMs that inactivate oxidation-specific epitopes (IgM), which are secondary products of lipid peroxidization, protect against inflammatory diseases, including diet-induced atherosclerosis. However, the human B cell subtype that produces IgM remains...
3.
Pattarabanjird T, Srikakulapu P, Ransegnola B, Marshall M, Ghosheh Y, Gulati R, et al.
Front Immunol
. 2024 Jan;
14:1296668.
PMID: 38259450
Circulating CD11c+ B cells, a novel subset of activated B cells, have been linked to autoimmunity and shown to expand with age. Atherosclerosis is an age-associated disease that involves innate...
4.
Iqneibi S, Saigusa R, Khan A, Oliaeimotlagh M, Suthahar S, Kumar S, et al.
Front Immunol
. 2023 Oct;
14:1239148.
PMID: 37828989
Coronary artery disease (CAD) is a major cause of death worldwide. The role of CD8+ T cells in CAD is unknown. Recent studies suggest a breakdown of tolerance in atherosclerosis,...
5.
Kim S, Wallin J, Ghosheh Y, Zahoor M, Vasquez J, Nkongolo S, et al.
JHEP Rep
. 2023 Aug;
5(9):100817.
PMID: 37600958
Background & Aims: Novel therapies for chronic hepatitis B (CHB), such as RNA interference, target all viral RNAs for degradation, whereas nucleoside analogues are thought to block reverse transcription with...
6.
Freuchet A, Roy P, Armstrong S, Oliaeimotlagh M, Kumar S, Orecchioni M, et al.
Nat Immunol
. 2023 Aug;
24(10):1748-1761.
PMID: 37563308
In atherosclerosis, some regulatory T (T) cells become exT cells. We crossed inducible T and exT cell lineage-tracker mice (FoxP3ROSA26) to atherosclerosis-prone Apoe mice, sorted T cells and exT cells...
7.
Lin J, Ehinger E, Hanna D, Qi Q, Wang T, Ghosheh Y, et al.
PLoS One
. 2023 May;
18(5):e0285926.
PMID: 37205656
Persistent inflammation contributes to the development of cardiovascular disease (CVD) as an HIV-associated comorbidity. Innate immune cells such as monocytes are major drivers of inflammation in men and women with...
8.
Nettersheim F, Ghosheh Y, Winkels H, Kobiyama K, Durant C, Armstrong S, et al.
Front Cardiovasc Med
. 2023 Jan;
9:1076808.
PMID: 36684560
Atherosclerotic cardiovascular diseases are the major cause of death worldwide. CD4 T cells responding to Apolipoprotein B (ApoB), the core protein of most lipoproteins, have been identified as critical disease...
9.
Santer D, Li D, Ghosheh Y, Zahoor M, Prajapati D, Hansen B, et al.
Nat Commun
. 2022 Nov;
13(1):6992.
PMID: 36385011
Interferons induced early after SARS-CoV-2 infection are crucial for shaping immunity and preventing severe COVID-19. We previously demonstrated that injection of pegylated interferon-lambda accelerated viral clearance in COVID-19 patients (NCT04354259)....
10.
Vallejo J, Saigusa R, Gulati R, Suthahar S, Suryawanshi V, Alimadadi A, et al.
BMC Biol
. 2022 Oct;
20(1):237.
PMID: 36266696
No abstract available.